iSTAR Medical completes enrolment of first-in-human MIGS trial

Novel MINIject device made from STAR® material successfully implanted in 25 patients

WAVRE, Belgium — 17 October 2017: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the completion of enrolment in their first-in-human (FIH) micro-invasive glaucoma surgery (MIGS) trial for the MINIjectTM device.

Read more